Find out from PQE experts how to perform a strong technology transfer to boost your vaccines production and meet compliance standards.
Covid-19 impacts the daily routine of Pharma manufacturers, raising new challenges for employees’ safety and products’ quality.
Manufacturers of API and finished products should cooperate with MAHs to prevent nitrosamine formation and contamination of human medicinal products.
